Publications
This bibliography contains links to literature and PubMed abstracts on topics related to Gaucher disease, including diagnosis, treatment therapies, comorbidities, cancer incidence, and disease registry analyses.
These publications were chosen by Sanofi Medical Affairs personnel. Additional resources on these topics are available and should be investigated.
Murugesan V, et al. Glucosylsphingosine is a key biomarker of Gaucher disease. Am J Hematol. 2016 Nov;91(11):1082–1089.
https://www.ncbi.nlm.nih.gov/pubmed/27441734
Mistry PK, et al. Understanding the natural history of Gaucher disease. Am J Hematol. 2015 Jul;90 (Suppl 1):S6–11.
https://www.ncbi.nlm.nih.gov/pubmed/26096746
Rosenbloom B, et al. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from
the ICGG Gaucher Registry. Blood Cells Mol Dis. 2011 Jan;46(1):95–102.
https://www.ncbi.nlm.nih.gov/pubmed/21067946
Kaplan P, et al. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis Arch Pediatr Adolesc Med. 2006 Jun;160(6):603–608.
Rosenbloom BE, et al. Gaucher disease and cancer incidence: a study from the Gaucher Registry. Blood. 2005 Jun;105(12):4569–4572.
https://www.ncbi.nlm.nih.gov/pubmed/16754822
Next in Gaucher Disease